Sibgha Gull Chaudhary

Health Innovations (United States) — United States

Medicine · Health Sciences

10h-index522citations137works0.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(64), Acute Myeloid Leukemia Research(50), Acute Lymphoblastic Leukemia research(37), Chronic Myeloid Leukemia Treatments(29), CAR-T cell therapy research(16)

Publications137 total

Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
Hematology Transfusion and Cell Therapy·2025Open Access
POSTER: ABCL-905 Outcomes in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: AML-911 Incidence, Patterns, and Outcomes of Invasive Fungal Infections in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: ALL-682 Outcomes of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory B-Cell Acute Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis
Clinical Lymphoma Myeloma & Leukemia·2025
AML-911: Incidence, Patterns, and Outcomes of Invasive Fungal Infections in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Clinical Lymphoma Myeloma & Leukemia·2025
ABCL-905: Outcomes in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
Clinical Lymphoma Myeloma & Leukemia·2025
ALL-682: Outcomes of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory B-Cell Acute Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis
Clinical Lymphoma Myeloma & Leukemia·2025
Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2025Open Access
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With Myelofibrosis
Clinical Lymphoma Myeloma & Leukemia·2025Open Access
Impact of body mass index on outcomes following allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation·2025
Factors associated with outcomes following reduced intensity conditioning haploidentical hematopoietic cell transplantation in acute myeloid leukemia.
Journal of Clinical Oncology·2025
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines
Bone Marrow Transplantation·2025· 1 cited
Allogeneic Hematopoietic Stem Cell Transplantation for Management of Histiocytic Sarcoma: A Systemic Review
Transplantation and Cellular Therapy·2025· 1 cited
Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
Transplantation and Cellular Therapy·2025· 1 cited
Outcomes after Matched Sibling Donor Versus Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
Transplantation and Cellular Therapy·2025
Outcomes of Outpatient CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory B-Cell Lymphomas: A Systematic Review and Meta-Analysis
Transplantation and Cellular Therapy·2025
Impact of Graft Cell Dose on Outcomes after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
Transplantation and Cellular Therapy·2025Open Access
Outcomes in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis
Transplantation and Cellular Therapy·2025Open Access
Outcomes of Melphalan Versus Busulfan with Fludarabine Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
Transplantation and Cellular Therapy·2025
Incidence and Severity of Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy: A Systemic Review and Meta-Analysis
Transplantation and Cellular Therapy·2025
page 1 of 7Next →

Frequent Co-authors

Muhammad Umair Mushtaq(49), Moazzam Shahzad(45), Joseph P. McGuirk(43), Iqra Anwar(29), Nausheen Ahmed(24), Sunil Abhyankar(24), Peiman Hematti(22), Muhammad Kashif Amin(18), Anurag K. Singh(17), Ezza Tariq(12), Haitham Abdelhakim(10), Rajat Bansal(10), Ramesh Balusu(10), Matthew McGuirk(10), Muhammad Usman Zafar(9), Leyla Shune(8), Natalie S. Callander(8), Iqra Anwar(7), Mehdi Hamadani(7), Sharad Khurana(6)